Centiva Capital’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Centiva Capital’s Portfolio NVACR Stock Details NVACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-150,000	Closed	-$18K	–	1875
2022 Q2	$18K	Hold	150,000	–	–	﹤0.01%	1509
2022 Q1	$21K	Buy	+150,000	New	+$25.2K	﹤0.01%	1479

Other funds holding NVACR

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Parkwood LLC Cleveland, Ohio $1.4B AUM 33.21% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Centiva Capital's NVACR Position: Q3 2022 in Review

Centiva Capital sold out of NorthView Acquisition Corporation Rights (NVACR) in Q3 2022, closing a stake of 150,000 shares — an estimated $18K sold.

Centiva Capital first reported a position in NVACR in Q1 2022 and held it in 2 quarters. The position peaked at $21K in Q1 2022. 39 funds tracked by Wall St. Rank hold NVACR as of Q3 2022.

Centiva Capital reported no remaining NorthView Acquisition Corporation Rights position as of Q3 2022 after selling out during the quarter.
Centiva Capital sold 150,000 NorthView Acquisition Corporation Rights shares in Q3 2022, an estimated $18K.
Centiva Capital first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 2 quarters.
Centiva Capital's NorthView Acquisition Corporation Rights position peaked at $21K in Q1 2022.
39 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.